0000874015-14-000023.txt : 20140117 0000874015-14-000023.hdr.sgml : 20140117 20140117194155 ACCESSION NUMBER: 0000874015-14-000023 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140115 FILED AS OF DATE: 20140117 DATE AS OF CHANGE: 20140117 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ISIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000874015 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330336973 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 BUSINESS PHONE: 7609319200 MAIL ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BENNETT C FRANK CENTRAL INDEX KEY: 0001073387 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19125 FILM NUMBER: 14536404 MAIL ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2014-01-15 0000874015 ISIS PHARMACEUTICALS INC ISIS 0001073387 BENNETT C FRANK C/O ISIS PHARMACEUTICALS, INC. 2855 GAZELLE COURT CARLSBAD CA 92010 0 1 0 0 SVP, Antisense Research Common Stock 2014-01-15 2014-01-15 4 M 0 1415 0 A 4445 D Common Stock 2014-01-16 2014-01-16 4 S 0 539 47.0811 D 3906 D Common Stock 2014-01-15 2014-01-15 4 M 0 695 0 A 4601 D Common Stock 2014-01-16 2014-01-16 4 S 0 265 47.081 D 4336 D Restricted Stock Units 2014-01-15 2014-01-15 4 A 0 7500 0 A Common Stock 7500 7500 D Restricted Stock Units 2014-01-15 2014-01-15 4 M 0 1415 0 D Common Stock 1415 4245 D Restricted Stock Units 2014-01-15 2014-01-15 4 M 0 695 0 D Common Stock 695 1388 D Acquired pursuant to vesting and release of shares pursuant to an RSU award granted on January 30, 2013. The sale was made pursuant to an automatic sale to cover the required tax withholding obligations pursuant to the 2011 Equity Incentive Plan Restricted Stock Unit Agreement and Grant Notice, dated January 30, 2013. Acquired pursuant to vesting and release of shares pursuant to an RSU award granted on January 15, 2012. The sale was made pursuant to an automatic sale to cover the required tax withholding obligations pursuant to the 2011 Equity Incentive Plan Restricted Stock Unit Agreement and Grant Notice, dated January 15, 2012. Each Restricted Stock Unit represents a contingent right to receive one share of Isis common stock, or its equivalent cash value. Grant 1/15/2014 to reporting person of Restricted Stock Units under the Isis Pharmaceuticals, Inc. 2011 Equity Incentive Plan. Restricted Stock Units vest in four equal annual installments, the first installment vesting on January 15, 2015. Upon vesting, the restricted stock units will be paid out in whole shares of Isis common stock or cash as may be determined by the Company. The RSU shall be fully vested on January 15, 2018. The RSU is vested as to 0 shares on January 15, 2014. Restricted Stock Unit Award granted on January 30, 2013. Restricted Stock Units vest in equal annual installments, the first installment vested on January 15, 2014. Upon vesting, the restricted stock units will be paid out in whole shares of Isis common stock or cash as may be determined by the Company. The RSU shall be fully vested on January 15, 2017. Restricted Stock Unit Award granted on January 15, 2012. Restricted Stock Units vest in equal annual installments, the first installment vested on January 15, 2013. Upon vesting, the restricted stock units will be paid out in whole shares of Isis common stock or cash as may be determined by the Company. The RSU shall be fully vested on January 15, 2016. /s/B. Lynne Parshall, attorney-in-fact 2014-01-17